MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
January 31, 2006
Stephen D. Simpson
Zimmer Muddles Through So long as the pressures in the orthopedic sector prove less than originally feared, investors could still make money here. mark for My Articles similar articles
The Motley Fool
February 1, 2005
Stephen D. Simpson
Zimmer Shoots From the Hip Pure-play orthopedic company delivers the goods, but at what cost? Zimmer carries a price tag that would make a value investor's bones ache. mark for My Articles similar articles
The Motley Fool
January 27, 2006
Rich Smith
Foolish Forecast: Boning Up on Zimmer With its margins as high as they are, and rising as steadily as they are, you won't be surprised to hear that the medical technology company's shares command premium prices. mark for My Articles similar articles
The Motley Fool
July 23, 2009
Robert Steyer
Long Convalescence for Device Makers Orthopedic product specialists Stryker and Zimmer Holdings forecast a slow-motion recovery. mark for My Articles similar articles
The Motley Fool
July 26, 2007
Ryan Fuhrmann
Zimmer Simmers The maker of hip and knee replacements gets a leg up on the market. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 30, 2007
Ryan Fuhrmann
Zimmer Implants a New High Investors, the orthopedic designer, developer, and manufacturer isn't cheap, but stellar companies rarely are. mark for My Articles similar articles
The Motley Fool
July 27, 2006
Stephen D. Simpson
Zimmer Provides Quarterly Information, and More In addition to its quarterly review, the orthopedic company gave some insight into the government probe. Investors, take note. mark for My Articles similar articles
The Motley Fool
April 27, 2006
Stephen D. Simpson
Guidance Brings Zimmer to Its Knees Sales were a little light this quarter, and the company will have to hustle to meet full-year projections. Investors, tread carefully and only buy when there is a fitting margin of safety here. mark for My Articles similar articles
The Motley Fool
October 25, 2007
Billy Fisher
Plenty of Strength in Zimmer Orthopedic manufacturer Zimmer Holdings reports a solid third quarter, but lowers its forecast for Q4. mark for My Articles similar articles
The Motley Fool
March 22, 2005
Stephen D. Simpson
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. mark for My Articles similar articles
The Motley Fool
January 27, 2006
Stephen D. Simpson
Lightning Stryker The dust hasn't yet settled on the orthopedic sector, so wise investors should tread lightly with this medical technology company. mark for My Articles similar articles
The Motley Fool
March 23, 2004
Glen Trematore
Stryker's a Warrior Need a new hip or a new addition to your portfolio? Consider Stryker. mark for My Articles similar articles
The Motley Fool
October 17, 2008
Brian Orelli
Shareholders Slap Stryker A little earnings miss sends the medical technology company down more than necessary. mark for My Articles similar articles
The Motley Fool
September 5, 2008
Brian Orelli
Zimmer Fortifies Its Spine The medical-device maker is buying Abbott's spine business. mark for My Articles similar articles
The Motley Fool
April 26, 2007
Ryan Fuhrmann
Zimmer Holding Steady: Fool by Numbers The orthopedic designer, developer, and manufacturer released first-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles
The Motley Fool
January 10, 2005
W.D. Crotty
This "dj" is Primed to Play Hits Medical device company dj Orthopedics reaps huge gains after a good sales report. mark for My Articles similar articles
The Motley Fool
October 18, 2007
Billy Fisher
An Empire Strykes Back Stryker reports a quarter of double-digit growth in revenue and earnings. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 28, 2005
Stephen D. Simpson
Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples. mark for My Articles similar articles
BusinessWeek
May 30, 2005
Michael Arndt
BW 50: A Test Of Zimmer's Agility Artificial joint maker Zimmer Holdings Inc. has the lead in a hot business. But the company faces a Justice probe and price pressures. mark for My Articles similar articles
The Motley Fool
July 23, 2010
Jordan DiPietro
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider? mark for My Articles similar articles
The Motley Fool
October 27, 2005
Stephen D. Simpson
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. mark for My Articles similar articles
The Motley Fool
April 30, 2004
W.D. Crotty
Ingram Micro Flops The world's largest technology wholesaler, Ingram Micro, did a belly flop in the New York stock exchange pool today. mark for My Articles similar articles
The Motley Fool
December 12, 2006
Matthew Crews
Smith & Nephew, What's the Deal? A merger with Biomet would be good in many ways. But what's the right price? Investors, take note. mark for My Articles similar articles
The Motley Fool
March 9, 2004
Rich Smith
Interpore Gets Transplanted Will its acquisition by medical equipment maker Biomet pay off for Interpore's shareholders? mark for My Articles similar articles
The Motley Fool
November 6, 2006
Matthew Crews
Smith & Nephew Is Hip to Growth The medical technology company is showing solid growth, but a possible acquisition is cause for concern. Investors, take note. mark for My Articles similar articles
The Motley Fool
July 21, 2006
Stephen D. Simpson
Stryker and the Terror of the Unknown This has been a pretty bad year to be a good medical technology company. Fears about future pricing and the DOJ investigation keep a lid on the entire sector. So, what about that future for Stryker? Investors, take note. mark for My Articles similar articles
The Motley Fool
April 27, 2007
Ryan Fuhrmann
Hip Results at Zimmer Holdings The orthopedic-implant and surgical-product maker is impressing investors, and it may just be warming up. mark for My Articles similar articles
The Motley Fool
April 16, 2004
Bill Mann
Stryker Hits It Again Stryker, the medical device company, reported year-over-year gains in revenues of 22%, with sales just over $1 billion. Earnings were even better: Stryker topped off last year's results by more than 30%. mark for My Articles similar articles
The Motley Fool
July 18, 2008
Brian Orelli
What Strikes Against Stryker? High growth isn't enough to impress investors. mark for My Articles similar articles
The Motley Fool
October 18, 2006
Matthew Crews
Stryker Is Steady Eddy How long can Stryker maintain its Steady Eddy persona? Net earnings will decelerate when gross margins peak. mark for My Articles similar articles
The Motley Fool
May 27, 2011
Andrew Tonner
Does Zimmer Holdings Deserve a Spot in Your Portfolio? Compared to it's peers, Zimmer Holdings doesn't look like a stock for your portfolio right now. mark for My Articles similar articles
The Motley Fool
February 27, 2004
Mark Mahorney
Shuffle Master's No Shell Game Gaming equipment company Shuffle Master had a big week, announcing two acquisitions and reporting fiscal first-quarter earnings. mark for My Articles similar articles
The Motley Fool
June 28, 2004
Rick Aristotle Munarriz
Food for Fiscal Thought Food makers will open the cupboards this week to take stock of their quarterly earnings. mark for My Articles similar articles
IndustryWeek
August 1, 2003
David Drickhamer
Profit Power! Our top 50 U.S. manufacturers leverage operational prowess for superior profitability. mark for My Articles similar articles
The Motley Fool
July 20, 2004
Rick Aristotle Munarriz
Margins of Error Profit margins matter. It's why we can get more excited about a company with rich margins when it grows sales -- we know that much more of the incremental dollar will work its way down to the bottom line unscathed. mark for My Articles similar articles
The Motley Fool
July 27, 2006
Stephen D. Simpson
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. mark for My Articles similar articles
The Motley Fool
September 21, 2005
Stephen D. Simpson
Can Biomet Stay Limber? Concerns about pricing have buffeted the orthopedic space and the No. 4 player in hips and knees. Whatever the case turns out to be, Biomet is probably a bit riskier than average. mark for My Articles similar articles
The Motley Fool
August 28, 2008
Brian Orelli
Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation. mark for My Articles similar articles
The Motley Fool
September 20, 2006
Ryan Fuhrmann
Biomet's Aching Joints Biomet operates in the appealing medical device industry, but current growth trends are giving investors a headache. mark for My Articles similar articles
The Motley Fool
January 28, 2009
Brian Orelli
The Streak Is Over After 31 consecutive quarters of double-digit sales growth, medical device maker Stryker finally had an off quarter. mark for My Articles similar articles
The Motley Fool
August 10, 2011
Evan Niu
One Medical-Device Stock to Buy MAKO Surgical delivers strong results. mark for My Articles similar articles
The Motley Fool
September 14, 2005
Stephen D. Simpson
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. mark for My Articles similar articles
The Motley Fool
April 26, 2005
Stephen D. Simpson
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. mark for My Articles similar articles
The Motley Fool
February 11, 2004
W.D. Crotty
Health-Care Opportunity Health Net looks like a value-priced managed care company. mark for My Articles similar articles
The Motley Fool
June 21, 2004
Seth Jayson
Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore. mark for My Articles similar articles
The Motley Fool
May 6, 2004
When There Are No Earnings You don't necessarily need earnings to evaluate a company. mark for My Articles similar articles
The Motley Fool
March 28, 2006
Stephen D. Simpson
A Surprising Turn at Biomet The large orthopedic company replaces one of its founders. This change doesn't really make the stock dramatically more, or less, attractive than before. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 28, 2011
Michael Olsen
Rising Star Buy: Zimmer Holdings Current trends, coupled with an aging population, should provide consistent and growing demand for Zimmer's wares. mark for My Articles similar articles
The Motley Fool
May 28, 2004
Roger Nusbaum
Stryker Stands Out This is one medical equipment maker that looks good. mark for My Articles similar articles
The Motley Fool
October 26, 2006
No Holding Back Zimmer: Fool by Numbers The maker of orthopedic implants released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles similar articles